Common Host Variants Influence Childhood ALL Risk
Leukemia published a 2025 review summarizing evidence that common germline variants influence childhood acute lymphoblastic leukemia susceptibility, treatment response, and toxicity, noting TPMT and NUDT15 are the only widely implemented pharmacogenetic markers. The authors identify limited effect sizes, ancestry-replication gaps, and unclear treatment strategies as barriers. They recommend large international cohorts, polygenic risk scores, and advanced machine-learning approaches to improve clinical translation.
Key Points
- 1Identify dozens of common germline variants associated with ALL susceptibility, treatment response, and toxicity risk
- 2Highlight limited clinical translation due to small effect sizes, ancestry gaps, and few replicated markers
- 3Recommend large international cohorts, PRS, and advanced ML to boost power and clinical utility
Scoring Rationale
Comprehensive peer-reviewed review with practical recommendations; limited novelty and modest direct clinical translation due to small effect sizes.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
